Edition:
United States

OncoTherapy Science Inc (4564.T)

4564.T on Tokyo Stock Exchange

244JPY
20 Oct 2017
Change (% chg)

¥-3 (-1.21%)
Prev Close
¥247
Open
¥246
Day's High
¥247
Day's Low
¥244
Volume
409,100
Avg. Vol
1,235,187
52-wk High
¥315
52-wk Low
¥221

Chart for

About

OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with... (more)
No analyst recommendations are available for .

Overall

Beta: 2.16
Market Cap(Mil.): ¥36,316.90
Shares Outstanding(Mil.): 147.03
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.36 16.99
EPS (TTM): -- -- --
ROI: -- 2.41 11.25
ROE: -- 3.35 15.06

BRIEF-OncoTherapy Science receives patent in Japan

* Says it received a patent (No.6159948 )for MELK specific inhibitors in Japan

Jul 12 2017

Earnings vs. Estimates